<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Legal Sleuth® ** Case Watch℠ - label change Archives &#8212; Gooch Law Firm</title>
	<atom:link href="https://legalsleuth.com/tag/label-change/feed/" rel="self" type="application/rss+xml" />
	<link>https://legalsleuth.com/tag/label-change/</link>
	<description>The Source for All Things Legal ℠ - Information, Resources and Services</description>
	<lastBuildDate>Sun, 18 Jan 2015 21:36:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://legalsleuth.com/wp-content/uploads/2016/02/icon-34-150x150.png</url>
	<title>Legal Sleuth® ** Case Watch℠ - label change Archives &#8212; Gooch Law Firm</title>
	<link>https://legalsleuth.com/tag/label-change/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Nuvaring Label Change</title>
		<link>https://legalsleuth.com/nuvaring-label-change/</link>
		
		<dc:creator><![CDATA[Legal Sleuth®]]></dc:creator>
		<pubDate>Tue, 11 Mar 2014 17:59:58 +0000</pubDate>
				<category><![CDATA[Medical Devices]]></category>
		<category><![CDATA[blood clots]]></category>
		<category><![CDATA[deep vein thrombosis]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[heart attacks]]></category>
		<category><![CDATA[label change]]></category>
		<category><![CDATA[nuvaring]]></category>
		<category><![CDATA[pulmonary embolisms]]></category>
		<category><![CDATA[strokes]]></category>
		<guid isPermaLink="false">http://legalsleuth.com/?p=5439</guid>

					<description><![CDATA[<p>Recently, the FDA issued a nuvaring label change.  Apparently, a nuvaring label change was approved by the FDA Center for Drug Evaluation and Research (CDER) on October 2013.  The nuvaring label change was related to Thromboembolic Disorders and Other Vascular Problems.  In particular, the nuvaring label change stated the following: Stop NuvaRing use if an [&#8230;]</p>
<p>The post <a href="https://legalsleuth.com/nuvaring-label-change/">Nuvaring Label Change</a> appeared first on <a href="https://legalsleuth.com">Legal Sleuth®</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
